Press Releases & Articles
— Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more — CAMBRIDGE, MA, Jan. 9, 2017– Novaseek Research LLC today announced that its Clinical Data Network for Research (CDNR) platform was recently enhanced to include the capability to dynamically collect biospecimens and clinical data from patients during the course of […]
Technological advances in an ever-changing healthcare environment, including the digitization of patient health records, have had a significant impact on the development of new therapies. Since first being used to support a drug’s value, real-world data (RWD) is now being pulled into the R&D process at earlier stages to impact the development of new medicines […]
BOSTON, Dec. 13, 2016– Novaseek Research LLC, a health information technology for life sciences company, today announced that Kate Torchilin, PhD, MBA, Chief Executive Officer, will present at the upcoming Digital Medicine Showcase 2017, which takes place concurrently with the JP Morgan 35th Annual Healthcare Conference in San Francisco. Dr. Torchilin’s presentation will take place […]
PharmaVoice 2017: “Industry experts discuss the potential of precision medicine and the impact this will have on R&D and commercial operations.
More Press Releases & Articles
These 17 women are transforming the healthcare industry with technologies designed to enhance efficiency, quality and access of care.
Last month, Foundation Medicine and Flatiron Health announced an initiative to assemble large genomic databases built around the electronic health records (EHRs), of 20,000 cancer patients. The purpose of this initiative would be to provide a real world data-based tool for oncology reseachers. It’s exciting to think about the possibilities that this type of database […]
With the advance of precision medicine, ensuring that clinical studies more accurately reflect real-world patients needs to be at the heart of drug discovery and development. Historically, one of the reasons that so many studies fail is because patient cohorts are often not defined optimally for the treatment being investigated. Step one in changing this […]
Precision medicine is an exciting area of innovation for researchers in academia and industry. It holds the promise of better outcomes for patients, and it is changing the way patients experience disease and treatment. By definition, the patient population for a targeted medicine is smaller than that of the disease category as a whole. Medicines affect patients differently.1 […]
The 2016 AAPS National Biotechnology Conference is the ideal venue to showcase Novaseek’s novel Clinical Data Network for Research (CDNR) platform for accessing the clinical data and biospecimens for research. Please visit us at Booth 403 and learn how Novaseek’s CDNR platform can inform your experiments and biospecimen requests with real world patient phenotype data, […]
More Blog Posts
We have received many emails about a recent Op-Ed in the New York Times – “Your Cells. Their Research. Your Permission?” By Rebecca Skloot (Dec. 30, 2015). In her piece, Ms. Sloot correctly points out that patient consent is a significant issue regarding the use of biospecimens in research: “Tissues from millions of Americans are […]